UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051891
Receipt number R000059210
Scientific Title Exploratory study of contributory factors of presbyopia
Date of disclosure of the study information 2023/08/15
Last modified on 2023/08/11 08:22:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of contributory factors of presbyopia

Acronym

Contributory factors of presbyopia

Scientific Title

Exploratory study of contributory factors of presbyopia

Scientific Title:Acronym

Contributory factors of presbyopia

Region

Japan


Condition

Condition

presbyopia

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore contributory factors of presbyopia in eye clinic patients

Basic objectives2

Others

Basic objectives -Others

To contibute to diagnosis and treatment of presbyopia by analysis of factors on presbyopia

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

severity of presbyopia

Key secondary outcomes

age, ocular findings


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

best corrected vusual acuity better than 20/30

Key exclusion criteria

within one month after eye surgery

Target sample size

100000


Research contact person

Name of lead principal investigator

1st name masahiko
Middle name
Last name ayaki

Organization

ootake eye clinic

Division name

eye

Zip code

1580082

Address

Yamato city, Kanagawa, Japan

TEL

09022118355

Email

mayaki@olive.ocn.ne.jp


Public contact

Name of contact person

1st name masahiko
Middle name
Last name ayaki

Organization

ootake eye clinic

Division name

eye

Zip code

1580082

Address

Yamato city, Kanagawa, Japan

TEL

09022118355

Homepage URL


Email

mayaki@olive.ocn.ne.jp


Sponsor or person

Institute

ootake eye clinic

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

kanagawa medical association

Address

yokohama, kanagawa

Tel

045-241-7000

Email

k-arai@kanagawa.med.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Suspended

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB

2015 Year 11 Month 06 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2033 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

severity of presbyopia, ocular findings


Management information

Registered date

2023 Year 08 Month 11 Day

Last modified on

2023 Year 08 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059210


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name